Scientific article
English

NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action

Published inBritish journal of pharmacology, vol. 164, no. 2b, p. 507-520
Publication date2011
Abstract

Celastrol is one of several bioactive compounds extracted from the medicinal plant Tripterygium wilfordii. Celastrol is used to treat inflammatory conditions, and shows benefits in models of neurodegenerative disease, cancer and arthritis, although its mechanism of action is incompletely understood.

Keywords
  • Animals
  • CHO Cells
  • Cell Line
  • Cell Line, Transformed
  • Cricetinae
  • Cytosol/drug effects/metabolism
  • HEK293 Cells
  • Humans
  • Hydrogen Peroxide/metabolism
  • NADPH Oxidase/antagonists & inhibitors/metabolism
  • Neutrophils/drug effects/metabolism
  • Onium Compounds/pharmacology
  • Oxidoreductases/metabolism
  • Oxygen/metabolism
  • Protein Binding/drug effects
  • Protein Isoforms
  • Protein Transport/drug effects
  • Reactive Oxygen Species/antagonists & inhibitors/metabolism
  • Superoxides/metabolism
  • Triterpenes/pharmacology
  • Src Homology Domains/drug effects
Citation (ISO format)
JAQUET, Vincent et al. NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. In: British journal of pharmacology, 2011, vol. 164, n° 2b, p. 507–520. doi: 10.1111/j.1476-5381.2011.01439.x
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0007-1188
751views
0downloads

Technical informations

Creation08/11/2012 15:08:00
First validation08/11/2012 15:08:00
Update08/01/2025 10:32:21
Status update08/01/2025 10:32:21
Last indexation08/01/2025 10:34:34
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack